 |
|
| • |
|
| • |
|
| • |
|
| • |
|
|
| • |
|
| • |
|
| • |
|
| • |
|
| • |
|
|
| • |
|
| • |
|
| • |
|
| • |
|
| • |
|
| • |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
Div. of Media Relations
1600 Clifton Road
MS D-14
Atlanta, GA 30333
(404) 639-3286
Fax (404) 639-7394 |
|
|
|
 |
Recommendations and Reports
May 19, 2000/Vol 49/No. RR
Poliomyelitis Prevention in the United States
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP)
These recommendations of the Advisory Committee on Immunization Practices (ACIP) for
poliomyelitis prevention replace those issued in 1997. As of January 1, 2000, ACIP recommends
exclusive use of inactivated poliovirus vaccine (IPV) for routine childhood polio vaccination
in the United States. All children should receive four doses of IPV at ages 2, 4, and 6-18
months and 4-6 years. Oral poliovirus vaccine (OPV) should be used only in certain
circumstances, which are detailed in these recommendations.
Contact: Division of Media Relations
CDC, Office of Communication
(404) 639–3286
|
